Search - tctmd.com

Displaying 1 - 20 of 34

Sort: Relevancy | Date

Presentation THT 2026

The Path Most Traveled: An Overview of the Breakthrough Device Designation — Can It Be Improved?

Presenter: JoAnn Lindenfeld

March 04, 2026

Presentation THT 2026

Design and Conduct of the INNOVATE Trial: Randomizing Durable LVAD Therapy in a High-Acuity Era

Presenter: Francis D. Pagani

March 04, 2026

Presentation THT 2026

Designing Studies for Gene Therapy for Rare Diseases

Presenter: Barry Greenberg

March 03, 2026

Presentation THT 2025

Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies

Presenter: David Cohen

February 13, 2025

Presentation THT 2025

This Strategy Has Saved the Startup Medical Device Sector

Presenter: William Abraham

February 13, 2025

Presentation THT 2025

Down-Stream Challenges: Reimbursement and Guidelines

Presenter: Philip Adamson

February 13, 2025

Presentation THT 2025

Position 2: All You Need Is Rate Control

Presenter: Akshay Desai

February 12, 2025

Presentation THT 2025

Challenges in Designing Collaborative Clinical Therapeutic Trials in HT

Presenter: Jeffrey Teuteberg

February 12, 2025

Presentation THT 2025

A Digital Platform to Optimize Guideline Directed Heart Failure Therapy: Primary Results of the AIM-POWER Randomized Controlled Trial

Presenter: Akshay Desai

February 12, 2025

Presentation THT 2025

Alleviant Implant Free Shunt: Learning and Adapting in Device and Trial Design

Presenter: James Udelson

February 12, 2025

Presentation THT 2025

A Device Designed for Patient Comfort - BrioVAD

Presenter: Jim Long

February 12, 2025

Presentation THT 2025

Heart Failure Management Using a Risk Score From an Insertable Cardiac Monitor: The Rationale and Design of the ALLEVIATE-HF Trial

Presenter: Javed Butler

February 11, 2025

Presentation THT 2025

Are Wearables and Smart Devices a More Scalable Solution

Presenter: Akshay Desai

February 11, 2025

Presentation THT 2024

Designing a Bionic Heart

Presenter: Ellen Roche

March 06, 2024

Presentation THT 2024

New Endpoints and Experimental Designs for Devices for Chronic Heart Failure (Breakthrough)

Presenter: William T. Abraham

March 06, 2024

Presentation THT 2024

A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms.

Presenter: Thomas Hanff

March 06, 2024

Presentation THT 2024

Designing Clinical Trials to Facilitate Better Implementation: Tips for Researchers

Presenter: Harriette G.C. Van Spall

March 05, 2024

Presentation THT 2024

A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1

Presenter: Lothar Roessig

March 05, 2024

Presentation THT 2024

Remote Patient Monitoring: Implications for Management of HF Patients During the Next Decade

Presenter: Akshay Desai

March 05, 2024

Presentation THT 2024

Inhibition of Hepatic Angiotensinogen Synthesis by an RNA Interference Therapeutic Agent: Implications for HTN and HF

Presenter: Akshay Desai

March 05, 2024

Advertisement

The Path Most Traveled: An Overview of the Breakthrough Device Designation — Can It Be Improved?

Design and Conduct of the INNOVATE Trial: Randomizing Durable LVAD Therapy in a High-Acuity Era

Designing Studies for Gene Therapy for Rare Diseases

Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies

This Strategy Has Saved the Startup Medical Device Sector

Down-Stream Challenges: Reimbursement and Guidelines

Position 2: All You Need Is Rate Control

Challenges in Designing Collaborative Clinical Therapeutic Trials in HT

A Digital Platform to Optimize Guideline Directed Heart Failure Therapy: Primary Results of the AIM-POWER Randomized Controlled Trial

Alleviant Implant Free Shunt: Learning and Adapting in Device and Trial Design

A Device Designed for Patient Comfort - BrioVAD

Heart Failure Management Using a Risk Score From an Insertable Cardiac Monitor: The Rationale and Design of the ALLEVIATE-HF Trial

Are Wearables and Smart Devices a More Scalable Solution

Designing a Bionic Heart

New Endpoints and Experimental Designs for Devices for Chronic Heart Failure (Breakthrough)

A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms.

Designing Clinical Trials to Facilitate Better Implementation: Tips for Researchers

A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1

Remote Patient Monitoring: Implications for Management of HF Patients During the Next Decade

Inhibition of Hepatic Angiotensinogen Synthesis by an RNA Interference Therapeutic Agent: Implications for HTN and HF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content